Recently, many sponsors have experienced increasing demand from regulators and payers to carry out cardiovascular outcomes trials (CVOT). Not only for mandated for Type2 Diabetes products but increasingly for other diseases and indications. This infographic addresses some of the frequently asked questions surrounding CVOTs presented from a former Cardiovascular Safety Outcome Trials Think Tank Meeting.
Have you considered:
- If you need a CVOT to support your product journey?
- What are the key considerations for performing a CVOT?
- When should a CVOT be carried out?